FORM 16A ICF Evaluation New
FORM 16A ICF Evaluation New
FORM 16A ICF Evaluation New
16A
ICF Evaluation Version No. 01
New ICF Date of Effectivity 01 Jan 22
3. The protocol includes adequate process for ensuring that the consent is voluntary.
( ) YES ( ) NO ( ) CANNOT TELL
4. There are different types of consent forms (assent, patient representative) appropriate for the types of study
participants.
( ) YES ( ) NO ( ) CANNOT TELL
5. The names and contact numbers of the research team and UVREC are in the informed consent.
( ) YES ( ) NO ( ) CANNOT TELL
6. The Informed Consent is translated into the local language/dialect. (if applicable)
( ) YES ( ) NO ( ) CANNOT TELL
7. OVERALL SUGGESTIONS
RECOMMENDATION: ( ) APPROVED
( ) Minor Revisions Required
____________________________________________________
____________________________________________________
( ) DISAPPROVED
_______________________________________________ ____________________________
Signature over Printed Name of the Reviewer Date Reviewed